Skip to main content
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2025 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2025 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2024 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Skip to main content
Latest news
Our company
Careers
Investors
Media center
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Discover J&J
Discover J&J
Discover J&J
Medicines & therapies
Medical devices & technology
News
Careers
Contact
Novel therapies
Overview
Investor news
Pipeline
Innovative Medicine pipeline
Development pipeline
Novel therapies
2025 Key events
Patent table
Financials
Quarterly results
Annual reports
SEC filings
Investor fact sheet
Events & presentations
Stock info
Stock quote
Stock chart
Historical stock quote
Investment calculator
Dividend history
Stock split information
Governance
Corporate governance overview
2025 Annual Meeting of Shareholders
Board of Directors
Executive Committee
ESG resources
2024 Health for Humanity Report
2024 Janssen Transparency Report
Resources
Investor FAQs
Information request form
Investor email alerts
Investor contacts
Novel Therapies
Novel Therapies -
Assets with $5B+ PYS Potential
Novel Therapies -
Assets with $1 – 5B PYS Potential
= Approved in US or EU
= Submitted in US or EU
Download report
(opens in new window)
Questions? Please contact us:
1-800-950-5089
investor-relations@its.jnj.com